Colgate-Palmolive (NYSE:CL) Shares Sold by Cascade Financial Partners LLC

Cascade Financial Partners LLC cut its holdings in shares of Colgate-Palmolive (NYSE:CL) by 5.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,615 shares of the company’s stock after selling 250 shares during the period. Cascade Financial Partners LLC’s holdings in Colgate-Palmolive were worth $420,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in CL. Kohmann Bosshard Financial Services LLC acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at $26,000. Centricity Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive during the 4th quarter worth about $27,000. Union Bancaire Privee UBP SA acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth about $32,000. Briaud Financial Planning Inc acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth about $32,000. Finally, OFI Invest Asset Management acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth about $36,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have commented on CL. Piper Sandler cut their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. TD Cowen cut their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. Morgan Stanley cut their price target on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. Raymond James restated an “outperform” rating and set a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Finally, UBS Group cut their price target on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and an average target price of $101.61.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $94.05 on Wednesday. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30. The stock has a market capitalization of $76.32 billion, a PE ratio of 26.72, a P/E/G ratio of 4.20 and a beta of 0.40. The firm has a 50 day moving average of $89.03 and a two-hundred day moving average of $94.99.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the previous year, the firm posted $0.87 earnings per share. On average, research analysts predict that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.